28 – 29

Menlo Park, CA
Quadrus Conference Center

View Map

Please join CureSearch for Children’s Cancer and Healthspottr for CureSearch Catapult 2016.

This invitational gathering is a rare opportunity for innovative researchers in the field of pediatric oncology to privately engage with leaders from pharma and biotech, experts in health policy and regulation, venture and philanthropic investors, and with thought-leading entrepreneurs and business service professionals. Through insightful debates and keynotes, small workshops and curated networking in an intimate setting, our day-and-a-half program seeks to discover new opportunities for collaboration between our funded researchers and these industry stakeholders so that we may establish a new roadmap for accelerating novel treatments to children in the clinic.


This event is made possible by the financial support of our sponsors and partners



WELCOME REMARKS | CureSearch President and CEO Laura S. Thrall

PANEL DISCUSSION | Why Catapult: Fording the Valley of Death

Carleen Hawn, CEO, Healthspottr

Our program moderator will describe the goals for the day, desired outcomes and our rules of engagement.

Dr. L. Mary Smith, Vice President of Product Development, United Therapeutics

Representatives of invited companies share strategically important lessons from a previous development project. Dr. Smith will discuss the strategy evolution that helped bring Unituxin to fruition for United Therapeutics. How might this development formula inform CureSearch investigators’ work? Includes Q&A.

Dr. Martha Donoghue, Pediatric Solid Tumors Scientific Liaison, United States Food and Drug Administration

Dr. Ralf Herold, Senior Scientific Officer, European Medicines Agency (via video conference)

Nancy Goodman, Founder and Executive Director, Kids v Cancer

Moderated by Carleen Hawn

Entrepreneurs at the leading edge of research, genomics and targeted therapeutics debate the new models and methods for accelerating potential cures to children in the clinic. In conversation with Jonathan Hirsch, Dr. Ethan Perlstein and Dr. Kevin Grimes.

Q&A moderated by Carleen Hawn.

Kenneth Schaner, Partner, Schaner & Lubitz PLLC

Representatives of invited companies share strategically important lessons from successful projects or companies. Kenneth Schaner, of Schaner & Lubitz PLLC, offers insights from his decades-long career facilitating successful partnerships between innovative researchers, commercial industry players and venture philanthropy investors. What can academic researchers focused on orphan diseases learn from these unique, three-pronged partnerships?

In conversation with CureSearch President and CEO Laura S. Thrall. Includes Q&A.

Dr. William Weiss, UCSF School of Medicine

Dr. Samuel Cheshier, Stanford School of Medicine

Dr. Crystal Mackall, Stanford School of Medicine

Working in two groups, participants will identify immediate opportunities to leverage our collective resources to help grantees clear a current development hurdle.

WORKSHOP A | Accelerating a Novel LSD-1 Inhibitor to Pediatric Clinical Trials for Ewing Sarcoma

WORKSHOP B | Driving Tumor Paint towards FDA Approval for Pediatric Brain Cancer

Confirmed Attendees

Prathima Acharya

Founder & Principal Consultant, Biosonata Consulting, LLC

Rajni Agarwal-Hashmi

Associate Professor of Pediatrics, Stanford School of Medicine

David Arthur

CEO, Salarius Pharmaceuticals, LLC

Rosa Bacchetta

Associate Professor of Pediatrics, Stanford School of Medicine

Samuel Blackman

SVP, Head of Clinical Development, Silverback Therapeutics, Inc.

Bruce Bloom

President & Chief Scientific Officer, Cures Within Reach

Christine Bork

Chief Development and Communications Officer, CureSearch

Susan Brumley

Vice President of Individual Giving, CureSearch

Eric Bubbers


Paula Carter

Co-Founder & Trustee, Scott Carter Foundation

Cason Carter

Representative, Scott Carter Foundation

Sam Cheshier

Assistant Professor of Pediatric Neurosurgery, Stanford School of Medicine

Brandon Cieniewicz

Postdoctoral Research Fellow, Stem Cell Transplantation, Stanford School of Medicine

Tom DeLay

COO, Healthspottr Media LLC

Martha Donoghue

Pediatric Solid Tumors Scientific Liaison, FDA

Robyn Donsky

Codman Neurosurgical Senior Account Executive, Johnson & Johnson

Debjani Dutta

Sr. Global Project Manager, Pharma Portfolio Management, Genentech

Betsy Eades

Senior Associate, Business Development, United Therapeutics

Heather Franklin

President & CEO, Blaze Bioscience

Peter Ginsberg

Senior Director, Business Development, United Therapeutics

Laurie Gomer

Director, Health System Partnerships, Syapse

Nancy Goodman

Executive Director, Kids v Cancer

Annie Gould

Childhood Cancer Advocate, CureSearch

Kevin Grimes

Co-director of the SPARK Translational Research Program, Stanford School of Medicine

Carleen Hawn

CEO & Co-Founder, Healthspottr Media LLC

Ralf Herold

Senior Scientific Officer, EMA

Jonathan Hirsch

Founder & President, Syapse

Richard Hutchins

Senior Director, Pharmaceutical Sciences, Pfizer

Margaret Laws

President & CEO, HopeLab

Wayne Lilyestrom

Group Manager, Medical Education and Research Grants, Genentech

Crystal Mackall

Professor of Pediatrics and Medicine, Stanford School of Medicine

Tess Mattingly

Senior Manager, Strategic Partnerships, CureSearch

Sandra Meech

Executive Director, Hematologic Malignancies Franchise Clinical Lead, Pfizer

Mike Miller

Partner, KMH Labor Law

Anna Musillami

Research and Network Development, Healthspottr Media LLC

Michael O’Connell

Global Pediatric Medical Director, Pfizer Pediatric Center of Excellence, Pfizer

Richard O’Reilly

Chair, Department of Pediatrics, Memorial Sloan Kettering Cancer Center

James Olson, MD, PhD

Attending Physician, Seattle Children's Hospital

Nancy Parker Taylo

Chief Strategy Officer, Stanford School of Medicine

Ethan Perlstein

Founder & CEO, Perlstein Lab

Allison Reimer

Operations Manager, Healthspottr Media LLC

Walt Rose

Honorary Board Member, Children's Hospital Los Angeles

Raphael Rousseau

Global Franchise Head, Pediatrics, Genentech, Genentech

Martine Roussel

Co-Leader, Cancer Genetics, Biochemistry & Cell Biology Program, St. Jude Children's Research Hospital

Nicole Rubin

Founder and Principal, Impact Solutions, LLC

Sarita Sastry, PhD

National Director, Research and Programs, CureSearch

Kenneth Schaner

Partner, Schaner & Lubitz PLLC

Sunil Sharma, MD

Chief of Medical Oncology, Huntsman Cancer Institute

David Shields

Director, Oncology Therapeutics Discovery, Pfizer

Stuart Siegel

Board Chair, CureSearch

L. Mary Smith

Vice President of Product Development, United Therapeutics

Sheri Sobrato

Trustee, The Sobrato Family Foundation

Lara Sullivan, MD

Vice President, Strategy & Portfolio Solutions, Worldwide Research & Development, Pfizer

Lisa Tichenor

President, QuadW Foundation

William Weiss

Professor, Departments of Neurology, Pediatrics, and Neurological Surgery, University of California - San Francisco

Kelli Wright

National Director of Strategic Partnerships, CureSearch

Sam Zucker

Partner, Sidley Austin LLP